Recurrent Hyperbilirubinemia with Midostaurin during Consolidation in a Patient of AML with FLT3 Mutation and Review of Literature for Alternative Maintenance Strategy

被引:0
作者
Shukla, Deepak Kumar [1 ]
Katewa, Satyendra [2 ]
Porwal, Ravikant [3 ]
机构
[1] Manipal Hosp, Jaipur 302013, Rajasthan, India
[2] Manipal Hosp, Jaipur, Rajasthan, India
[3] Manipal Hosp, Infect Dis, Jaipur, Rajasthan, India
关键词
AML; FLT3; mutation; midostaurin; hyperbilirubinemia; sorafenib; ACUTE MYELOID-LEUKEMIA; PROGNOSTIC RELEVANCE; PLUS CHEMOTHERAPY; OLDER PATIENTS; TRANSPLANTATION; AZACITIDINE; VENETOCLAX;
D O I
10.1055/s-0043-1772255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Midostaurin-induced hyperbilirubinemia during consolidation chemotherapy is uncommon. Dose-modification strategy for midostaurin in presence of hyperbilirubinemia remains undefined. We report a case of a young woman diagnosed as acute myeloid leukemia having normal cytogenetics with FLT3-ITD (internal tandem duplication) mutation who tolerated midostaurin during induction but developed recurrent hyperbilirubinemia without transaminitis with midostaurin during high-dose cytarabine consolidation. The pattern of hyperbilirubinemia with midostaurin was transient and rapidly reversible on stopping the drug, but recurred thrice. Sanger sequencing for UGT1A1*28 polymorphism failed to detect relevant variations. In the absence of any other approved FLT3 inhibitor in first line setting, she received sorafenib maintenance at 200 mg twice daily in combination with subcutaneous azacitidine. The combination was well tolerated without hyperbilirubinemia with sorafenib.
引用
收藏
页码:427 / 431
页数:5
相关论文
共 30 条
[1]  
Ah YM, 2008, DRUG METAB REV, V40, P511, DOI [10.1080/03602530802341133, 10.1080/03602530802341133 ]
[2]   A Phase II Study of Azacitidine Plus Venetoclax As Maintenance Therapy in Acute Myeloid Leukemia: Durable Responses with Longer Term Follow- [J].
Bazinet, Alexandre ;
Kantarjian, Hagop ;
Borthakur, Gautam ;
Yilmaz, Musa ;
Bose, Prithviraj ;
Jabbour, Elias ;
Alvarado, Yesid ;
Chien, Kelly S. ;
Pemmaraju, Naveen ;
Takahashi, Koichi ;
Short, Nicholas ;
Daver, Naval ;
Issa, Ghayas C. ;
Jain, Nitin ;
Linderman, Debra Bull ;
DiNardo, Courtney D. ;
Burger, Jan A. ;
Ferrajoli, Alessandra ;
Montalban-Bravo, Guillermo ;
Garcia-Manero, Guillermo ;
Sasaki, Koji ;
Ravandi, Farhad ;
Kadia, Tapan M. .
BLOOD, 2022, 140 :9005-9007
[3]   Hematopoietic stem cell transplantation for patients with AML in first complete remission [J].
Cornelissen, Jan J. ;
Blaise, Didier .
BLOOD, 2016, 127 (01) :62-70
[4]   Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].
DiNardo, C. D. ;
Jonas, B. A. ;
Pullarkat, V. ;
Thirman, M. J. ;
Garcia, J. S. ;
Wei, A. H. ;
Konopleva, M. ;
Doehner, H. ;
Letai, A. ;
Fenaux, P. ;
Koller, E. ;
Havelange, V. ;
Leber, B. ;
Esteve, J. ;
Wang, J. ;
Pejsa, V. ;
Hajek, R. ;
Porkka, K. ;
Illes, A. ;
Lavie, D. ;
Lemoli, R. M. ;
Yamamoto, K. ;
Yoon, S. -S. ;
Jang, J. -H. ;
Yeh, S. -P. ;
Turgut, M. ;
Hong, W. -J. ;
Zhou, Y. ;
Potluri, J. ;
Pratz, K. W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629
[5]   Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN [J].
Doehner, Hartmut ;
Wei, Andrew H. ;
Appelbaum, Frederick R. ;
Craddock, Charles ;
DiNardo, Courtney D. ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Godley, Lucy A. ;
Hasserjian, Robert P. ;
Larson, Richard A. ;
Levine, Ross L. ;
Miyazaki, Yasushi ;
Niederwieser, Dietger ;
Ossenkoppele, Gert ;
Roellig, Christoph ;
Sierra, Jorge ;
Stein, Eytan M. ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wang, Jianxiang ;
Wierzbowska, Agnieszka ;
Lowenberg, Bob .
BLOOD, 2022, 140 (12) :1345-1377
[6]   Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia [J].
Doehner, Konstanze ;
Thiede, Christian ;
Jahn, Nikolaus ;
Panina, Ekaterina ;
Gambietz, Agnes ;
Larson, Richard A. ;
Prior, Thomas W. ;
Marcucci, Guido ;
Jones, Dan ;
Krauter, Juergen ;
Heuser, Michael ;
Voso, Maria Teresa ;
Ottone, Tiziana ;
Nomdedeu, Josep F. ;
Mandrekar, Sumithra J. ;
Klisovic, Rebecca B. ;
Wei, Andrew H. ;
Sierra, Jorge ;
Sanz, Miguel A. ;
Brandwein, Joseph M. ;
de Witte, Theo ;
Jansen, Joop H. ;
Niederwieser, Dietger ;
Appelbaum, Frederick R. ;
Medeiros, Bruno C. ;
Tallman, Martin S. ;
Schlenk, Richard F. ;
Ganser, Arnold ;
Serve, Hubert ;
Ehninger, Gerhard ;
Amadori, Sergio ;
Gathmann, Insa ;
Benner, Axel ;
Pallaud, Celine ;
Stone, Richard M. ;
Doehner, Hartmut ;
Bloomeld, Clara D. .
BLOOD, 2020, 135 (05) :371-380
[7]  
Erba H, 2022, HEMASPHERE, V6, P1, DOI [10.1097/01.hs9.0000843296.73803.85, DOI 10.1097/01.HS9.0000843296.73803.85, 10.1097/01.hs9.0000843296.73803.85]
[8]   Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia [J].
Freeman, Sylvie D. ;
Virgo, Paul ;
Couzens, Steve ;
Grimwade, David ;
Russell, Nigel ;
Hills, Robert K. ;
Burnett, Alan K. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) :4123-+
[9]   Relapse risk and survival in patients with FLT3 mutated acute myeloid leukemia undergoing stem cell transplantation [J].
Gaballa, Sameh ;
Saliba, Rima ;
Oran, Betul ;
Brammer, Jonathan E. ;
Chen, Julianne ;
Rondon, Gabriela ;
Alousi, Amin M. ;
Kebriaei, Partow ;
Marin, David ;
Popat, Uday R. ;
Andersson, Borje S. ;
Shpall, Elizabeth J. ;
Jabbour, Elias ;
Daver, Naval ;
Andreeff, Michael ;
Ravandi, Farhad ;
Cortes, Jorge ;
Patel, Keyur ;
Champlin, Richard E. ;
Ciurea, Stefan O. .
AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (04) :331-337
[10]   Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients [J].
Huls, Gerwin ;
Chitu, Dana A. ;
Havelange, Violaine ;
Jongen-Lavrencic, Mojca ;
van de Loosdrecht, Arjan A. ;
Biemond, Bart J. ;
Sinnige, Harm ;
Hodossy, Beata ;
Graux, Carlos ;
Kooy, Rien van Marwijk ;
de Weerdt, Okke ;
Breems, Dimitri ;
Klein, Saskia ;
Kuball, Jurgen ;
Deeren, Dries ;
Terpstra, Wim ;
Vekemans, Marie-Christiane ;
Ossenkoppele, Gert J. ;
Vellenga, Edo ;
Lowenberg, Bob ;
Breems, D. A. ;
Verhoef, G. ;
Schuermans, C. ;
Terpstra, J. ;
Van Esser, J. W. J. ;
van Lammeren-Venema, D. ;
Legdeur, M. C. J. C. ;
Jie, G. K. S. ;
van der Velden, W. ;
Lowenberg, B. .
BLOOD, 2019, 133 (13) :1457-1464